Clinical Trials Browser

INDUSTRY × Interventional × Lymphangioma × Clear all

NCT05948943 2026-06-02

EPIK-L1

Phase 2/3 Recruiting

Lymphangioma, Lymphangioma, Cystic, Lymphatic Abnormalities

NCT06239480 2026-03-27

SELVA

Phase 3 Active not recruiting

Congenital Abnormalities, Lymphangioma, Lymphatic Abnormalities, Vascular Malformations

NCT05050149 2025-01-17

Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations

Phase 2 Completed

12 enrolled 7 charts

Lymphangioma